A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies

NCT04288141 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

OTHER: Acquisition of blood samples and tumour tissue samples (biopsies)

Sponsor

King's College London

Collaborators

[object Object]
[object Object]